UPDATE: Imperial Capital Initiates Coverage on Medifast on Attractive Entry Point

In a report published Friday, Imperial Capital analyst Mitchell B. Pinheiro initiated coverage on Medifast (NYSE: MED ) with an Outperform rating and $30.00 price target. In the report, Imperial Capital noted, “We are initiating coverage of Medifast, Inc. (MED) with an Outperform rating and a one-year price target of